Td Private Client Wealth LLC Pacira Bio Sciences, Inc. Transaction History

Td Private Client Wealth LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $12,163 - $15,030	477 New	477 $13.6 Million
Q1 2024 Aug 16, 2024	SELL	$27.7 - $35.48 $2,576 - $3,299	-93 Reduced 65.03%	50 $1.46 Million
Q3 2023 Aug 16, 2024	SELL	$30.68 - $40.09 $245 - $320	-8 Reduced 5.3%	143 $4.39 Million
Q1 2023 Aug 16, 2024	SELL	$35.53 - $43.38 $11,582 - $14,141	-326 Reduced 68.34%	151 $6.16 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.